109 related articles for article (PubMed ID: 16988460)
1. Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-β.
Mørkholt AS; Kastaniegaard K; Trabjerg MS; Gopalasingam G; Niganze W; Larsen A; Stensballe A; Nielsen S; Nieland JD
Sci Rep; 2018 May; 8(1):7092. PubMed ID: 29728570
[TBL] [Abstract][Full Text] [Related]
2. Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.
Theil DJ; Libbey JE; Rodriguez F; Whitton JL; Tsunoda I; Derfuss TJ; Fujinami RS
J Neuroimmunol; 2008 Nov; 204(1-2):92-100. PubMed ID: 18706703
[TBL] [Abstract][Full Text] [Related]
3. Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE).
Tutaj M; Szczepanik M
J Autoimmun; 2007 Jun; 28(4):208-15. PubMed ID: 17442539
[TBL] [Abstract][Full Text] [Related]
4. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
[TBL] [Abstract][Full Text] [Related]
5. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A
Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757
[TBL] [Abstract][Full Text] [Related]
6. Protection from autoimmunity by DNA vaccination against T-cell receptor.
Buch T; Waisman A
Methods Mol Med; 2006; 127():269-80. PubMed ID: 16988460
[TBL] [Abstract][Full Text] [Related]
7. Initiation and regulation of CNS autoimmunity.
Goverman J; Brabb T; Paez A; Harrington C; von Dassow P
Crit Rev Immunol; 1997; 17(5-6):469-80. PubMed ID: 9419434
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
Fontoura P; Garren H; Steinman L
Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989
[TBL] [Abstract][Full Text] [Related]
9. MASTering the immune response: mast cells in autoimmunity.
Gregory GD; Bickford A; Robbie-Ryan M; Tanzola M; Brown MA
Novartis Found Symp; 2005; 271():215-25; discussion 225-31. PubMed ID: 16605138
[TBL] [Abstract][Full Text] [Related]
10. T-cell vaccination in multiple sclerosis.
Achiron A; Mandel M
Autoimmun Rev; 2004 Jan; 3(1):25-32. PubMed ID: 14871646
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
